Android Apple

FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer

By Yahoo! Finance   |   4 months ago
FDA Approves AstraZeneca's Blockbuster Cancer Drug, Imfinzi, In Combination With Chemo For Non-Small Cell Lung Cancer

The FDA approved AstraZeneca's Imfinzi in combination with chemo for early-stage non-small cell lung cancer. Imfinzi showed significant benefits in reducing recurrence and progression events. The drug is also under review for limited-stage small cell lung cancer.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.